Skip to main content
Top
Published in: Cancer Causes & Control 12/2012

01-12-2012 | Original paper

The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland

Authors: Satu-Liisa Pauniaho, Jonna Salonen, Mika Helminen, Kim Vettenranta, Markku Heikinheimo, Oskari Heikinheimo

Published in: Cancer Causes & Control | Issue 12/2012

Login to get access

Abstract

Purpose

Germ cell tumors (GCTs) comprise a heterogeneous group of tumors derived from primordial germ cells. The incidence of malignant testicular GCTs has increased in recent decades, but little is known about possible changes in malignant female GCTs. Population-based data covering all malignant GCTs in both sexes remain limited.

Methods

All cases of malignant GCTs in 1969–2008 were collected from the Finnish Cancer Registry and their age-adjusted annual incidences calculated.

Results

The overall incidence of malignant GCTs was 2.56 per 100,000 person-years in males and 0.34 per 100,000 in females. The incidence of gonadal GCTs increased from 2.27 to 8.36 per 100,000 in males between 15 and 44 years of age. Moreover, the incidence of all histological subtypes of gonadal GCTs increased in males. In females, the only increase was seen in the incidence of ovarian non-dysgerminoma (from 0.07 to 0.29/100,000). The incidence of extragonadal GCTs did not change during the study period, being 0.18 and 0.10 per 100,000 in males and females, respectively.

Conclusions

The incidence of gonadal GCTs in males increased significantly during the 40-year study period, whereas in females, no such change was observed. There were significant gender differences regarding the distribution of histological subtypes and patients’ ages. However, the incidence of extragonadal GCTs remained low in both sexes. The differences in the incidences of gonadal GCTs derived from the same population suggest that the risk factors of these malignancies differ between the two sexes.
Literature
1.
go back to reference Schneider DT, Calaminus G, Koch S et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169–175PubMedCrossRef Schneider DT, Calaminus G, Koch S et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169–175PubMedCrossRef
2.
go back to reference McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70PubMedCrossRef
3.
go back to reference Agnarsson BA, Gudbjartsson T, Einarsson GV et al (2006) Testicular germ cell tumours in Iceland: a nationwide clinicopathological study. APMIS 114:779–783PubMedCrossRef Agnarsson BA, Gudbjartsson T, Einarsson GV et al (2006) Testicular germ cell tumours in Iceland: a nationwide clinicopathological study. APMIS 114:779–783PubMedCrossRef
4.
go back to reference Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085PubMedCrossRef Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085PubMedCrossRef
5.
go back to reference Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer (Epub ahead of print) Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer (Epub ahead of print)
6.
go back to reference Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. APMIS 111:43–46 (discussion 46–8) Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. APMIS 111:43–46 (discussion 46–8)
7.
go back to reference Stang A, Trabert B, Wentzensen N, et al. (2012) Gonadal and extragonadal germ cell tumours in the United States, 1973–2007. Int J Androl (Epub ahead of print) Stang A, Trabert B, Wentzensen N, et al. (2012) Gonadal and extragonadal germ cell tumours in the United States, 1973–2007. Int J Androl (Epub ahead of print)
9.
go back to reference Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef
10.
go back to reference Schmiedel S, Schuz J, Skakkebaek NE, Johansen C (2010) Testicular germ cell cancer incidence in an immigration perspective, Denmark, 1978 to 2003. J Urol 183:1378–1382PubMedCrossRef Schmiedel S, Schuz J, Skakkebaek NE, Johansen C (2010) Testicular germ cell cancer incidence in an immigration perspective, Denmark, 1978 to 2003. J Urol 183:1378–1382PubMedCrossRef
11.
go back to reference Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13:2157–2166PubMed Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13:2157–2166PubMed
12.
go back to reference Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159PubMedCrossRef Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159PubMedCrossRef
13.
go back to reference Ioka A, Tsukuma H, Ajiki W, Oshima A (2003) Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 94:292–296PubMedCrossRef Ioka A, Tsukuma H, Ajiki W, Oshima A (2003) Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 94:292–296PubMedCrossRef
14.
go back to reference Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14PubMedCrossRef Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14PubMedCrossRef
15.
go back to reference Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978PubMedCrossRef Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978PubMedCrossRef
16.
go back to reference Jorgensen N, Vierula M, Jacobsen R et al (2011) Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 34:e37–e48PubMedCrossRef Jorgensen N, Vierula M, Jacobsen R et al (2011) Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 34:e37–e48PubMedCrossRef
17.
go back to reference McGlynn KA, Cook MB (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5:1389–1402PubMedCrossRef McGlynn KA, Cook MB (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5:1389–1402PubMedCrossRef
18.
go back to reference Wanderas EH, Grotmol T, Fossa SD, Tretli S (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9:475–486PubMedCrossRef Wanderas EH, Grotmol T, Fossa SD, Tretli S (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9:475–486PubMedCrossRef
19.
go back to reference Gershman ST, Stolley PD (1988) A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 17:738–742PubMedCrossRef Gershman ST, Stolley PD (1988) A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 17:738–742PubMedCrossRef
20.
go back to reference Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T (2006) Risk factors for testicular cancer—differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl 29:458–467PubMedCrossRef Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T (2006) Risk factors for testicular cancer—differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl 29:458–467PubMedCrossRef
21.
go back to reference Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151–1155PubMed Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151–1155PubMed
22.
go back to reference Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC, Oliver RT (2004) Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 15:277–283PubMedCrossRef Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC, Oliver RT (2004) Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 15:277–283PubMedCrossRef
23.
go back to reference Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28PubMedCrossRef Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28PubMedCrossRef
24.
go back to reference Waheeb R, Hofmann MC (2011) Human spermatogonial stem cells: a possible origin for spermatocytic seminoma. Int J Androl 34:296–305CrossRef Waheeb R, Hofmann MC (2011) Human spermatogonial stem cells: a possible origin for spermatocytic seminoma. Int J Androl 34:296–305CrossRef
25.
go back to reference Altman DG (2000) Statistics with confidence: confidence intervals and statistical guidelines. BMJ Books, London, p xii, 240 s Altman DG (2000) Statistics with confidence: confidence intervals and statistical guidelines. BMJ Books, London, p xii, 240 s
26.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef
27.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 6:469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 6:469–481PubMedCrossRef
28.
go back to reference Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA (2011) Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl 34:e274–e277PubMedCrossRef Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA (2011) Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl 34:e274–e277PubMedCrossRef
29.
go back to reference Pukkala E (2011) Biobanks and registers in epidemiologic research on cancer. Methods Mol Biol 675:127–164PubMedCrossRef Pukkala E (2011) Biobanks and registers in epidemiologic research on cancer. Methods Mol Biol 675:127–164PubMedCrossRef
30.
go back to reference Baade P, Carriere P, Fritschi L (2008) Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 19:1043–1049PubMedCrossRef Baade P, Carriere P, Fritschi L (2008) Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 19:1043–1049PubMedCrossRef
31.
go back to reference Walschaerts M, Huyghe E, Muller A, Bachaud JM, Bujan L, Thonneau P (2008) Doubling of testicular cancer incidence rate over the last 20 years in southern France. Cancer Causes Control 19:155–161PubMedCrossRef Walschaerts M, Huyghe E, Muller A, Bachaud JM, Bujan L, Thonneau P (2008) Doubling of testicular cancer incidence rate over the last 20 years in southern France. Cancer Causes Control 19:155–161PubMedCrossRef
32.
go back to reference Trama A, Mallone S, Nicolai N et al (2012) Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer 48:159–169PubMedCrossRef Trama A, Mallone S, Nicolai N et al (2012) Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer 48:159–169PubMedCrossRef
Metadata
Title
The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland
Authors
Satu-Liisa Pauniaho
Jonna Salonen
Mika Helminen
Kim Vettenranta
Markku Heikinheimo
Oskari Heikinheimo
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0069-9

Other articles of this Issue 12/2012

Cancer Causes & Control 12/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine